APO Research
Talk to an analyst

APO RESEARCH · REPORT

Beauty Peptide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Beauty Peptide Industry Growth and Trends Forecast to 2032

10 April 202694 pages

Choose your research edition.

Industry ResearchBeauty Peptide Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Beauty Peptide Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Beauty Peptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Beauty Peptide Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Beauty Peptide Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Beauty Peptide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Beauty Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Beauty Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Beauty Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Beauty Peptide include Readline Biotech, Pentapharm, Pentapharm, Lipotec, ISP, Helix BioMedix, Evonil and Atrium, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Beauty Peptide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Beauty Peptide market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Beauty Peptide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Beauty Peptide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Beauty Peptide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Beauty Peptide Market by Company

Readline Biotech

Pentapharm

Pentapharm

Lipotec

ISP

Helix BioMedix

Evonil

Atrium

Beauty Peptide Segment by Type

Signal Peptides

Neurotransmitter-Inhibiting Peptides

Carried Peptides

Beauty Peptide Segment by Application

Anti-ageing

Whitening

Others

Beauty Peptide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beauty Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Beauty Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beauty Peptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Beauty Peptide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Beauty Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Signal Peptides Table 2. Major Company of Neurotransmitter-Inhibiting Peptides Table 3. Major Company of Carried Peptides Table 4. Global Beauty Peptide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Beauty Peptide Sales by Type (2021-2026) & (t) Table 6. Global Beauty Peptide Sales Market Share in Volume by Type (2021-2026) Table 7. Global Beauty Peptide Sales by Type (2021-2026) & (US$ Million) Table 8. Global Beauty Peptide Sales Market Share in Value by Type (2021-2026) Table 9. Global Beauty Peptide Price by Type (2021-2026) & (USD/t) Table 10. Global Beauty Peptide Sales by Type (2027-2032) & (t) Table 11. Global Beauty Peptide Sales Market Share in Volume by Type (2027-2032) Table 12. Global Beauty Peptide Sales by Type (2027-2032) & (US$ Million) Table 13. Global Beauty Peptide Sales Market Share in Value by Type (2027-2032) Table 14. Global Beauty Peptide Price by Type (2027-2032) & (USD/t) Table 15. North America Beauty Peptide Sales by Type (2021-2026) & (t) Table 16. North America Beauty Peptide Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Beauty Peptide Sales by Type (2021-2026) & (t) Table 18. Europe Beauty Peptide Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Beauty Peptide Sales by Type (2021-2026) & (t) Table 20. Asia-Pacific Beauty Peptide Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Beauty Peptide Sales by Type (2021-2026) & (t) Table 22. Latin America Beauty Peptide Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Beauty Peptide Sales by Type (2021-2026) & (t) Table 24. Middle East and Africa Beauty Peptide Sales by Type (2021-2026) & (US$ Million) Table 25. Beauty Peptide Industry Trends Table 26. Beauty Peptide Industry Drivers Table 27. Beauty Peptide Industry Opportunities and Challenges Table 28. Beauty Peptide Industry Restraints Table 29. Global Beauty Peptide Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Beauty Peptide Revenue Market Share by Company (2021-2026) Table 31. Global Beauty Peptide Sales by Company (2021-2026) & (t) Table 32. Global Beauty Peptide Sales Share by Company (2021-2026) Table 33. Global Beauty Peptide Market Price by Company (2021-2026) & (USD/t) Table 34. Global Beauty Peptide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Beauty Peptide Major Company Production Sites and Headquarters Table 36. Global Beauty Peptide Company, Product Type & Application Table 37. Global Beauty Peptide Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Beauty Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Beauty Peptide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Beauty Peptide Sales by Region (2021-2026) & (t) Table 42. Global Beauty Peptide Sales Market Share in Volume by Region (2021-2026) Table 43. Global Beauty Peptide Sales by Region (2021-2026) & (US$ Million) Table 44. Global Beauty Peptide Sales Market Share in Value by Region (2021-2026) Table 45. Global Beauty Peptide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 46. Global Beauty Peptide Sales by Region (2027-2032) & (t) Table 47. Global Beauty Peptide Sales Market Share in Volume by Region (2027-2032) Table 48. Global Beauty Peptide Sales by Region (2027-2032) & (US$ Million) Table 49. Global Beauty Peptide Sales Market Share in Value by Region (2027-2032) Table 50. Global Beauty Peptide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 51. Global Beauty Peptide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Beauty Peptide Sales by Application (2021-2026) & (t) Table 53. Global Beauty Peptide Sales Market Share in Volume by Application (2021-2026) Table 54. Global Beauty Peptide Sales by Application (2021-2026) & (US$ Million) Table 55. Global Beauty Peptide Sales Market Share in Value by Application (2021-2026) Table 56. Global Beauty Peptide Price by Application (2021-2026) & (USD/t) Table 57. Global Beauty Peptide Sales by Application (2027-2032) & (t) Table 58. Global Beauty Peptide Sales Market Share in Volume by Application (2027-2032) Table 59. Global Beauty Peptide Sales by Application (2027-2032) & (US$ Million) Table 60. Global Beauty Peptide Sales Market Share in Value by Application (2027-2032) Table 61. Global Beauty Peptide Price by Application (2027-2032) & (USD/t) Table 62. North America Beauty Peptide Sales by Application (2021-2026) & (t) Table 63. North America Beauty Peptide Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Beauty Peptide Sales by Application (2021-2026) & (t) Table 65. Europe Beauty Peptide Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Beauty Peptide Sales by Application (2021-2026) & (t) Table 67. Asia-Pacific Beauty Peptide Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Beauty Peptide Sales by Application (2021-2026) & (t) Table 69. Latin America Beauty Peptide Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Beauty Peptide Sales by Application (2021-2026) & (t) Table 71. Middle East and Africa Beauty Peptide Sales by Application (2021-2026) & (US$ Million) Table 72. Readline Biotech Company Information Table 73. Readline Biotech Business Overview Table 74. Readline Biotech Beauty Peptide Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. Readline Biotech Beauty Peptide Product Portfolio Table 76. Readline Biotech Recent Development Table 77. Pentapharm Company Information Table 78. Pentapharm Business Overview Table 79. Pentapharm Beauty Peptide Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 80. Pentapharm Beauty Peptide Product Portfolio Table 81. Pentapharm Recent Development Table 82. Pentapharm Company Information Table 83. Pentapharm Business Overview Table 84. Pentapharm Beauty Peptide Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 85. Pentapharm Beauty Peptide Product Portfolio Table 86. Pentapharm Recent Development Table 87. Lipotec Company Information Table 88. Lipotec Business Overview Table 89. Lipotec Beauty Peptide Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 90. Lipotec Beauty Peptide Product Portfolio Table 91. Lipotec Recent Development Table 92. ISP Company Information Table 93. ISP Business Overview Table 94. ISP Beauty Peptide Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 95. ISP Beauty Peptide Product Portfolio Table 96. ISP Recent Development Table 97. Helix BioMedix Company Information Table 98. Helix BioMedix Business Overview Table 99. Helix BioMedix Beauty Peptide Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 100. Helix BioMedix Beauty Peptide Product Portfolio Table 101. Helix BioMedix Recent Development Table 102. Evonil Company Information Table 103. Evonil Business Overview Table 104. Evonil Beauty Peptide Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 105. Evonil Beauty Peptide Product Portfolio Table 106. Evonil Recent Development Table 107. Atrium Company Information Table 108. Atrium Business Overview Table 109. Atrium Beauty Peptide Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 110. Atrium Beauty Peptide Product Portfolio Table 111. Atrium Recent Development Table 112. North America Beauty Peptide Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 113. North America Beauty Peptide Sales by Country (2021-2026) & (t) Table 114. North America Beauty Peptide Sales Market Share by Country (2021-2026) Table 115. North America Beauty Peptide Sales Forecast by Country (2027-2032) & (t) Table 116. North America Beauty Peptide Sales Market Share Forecast by Country (2027-2032) Table 117. North America Beauty Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Beauty Peptide Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Beauty Peptide Market Share by Country (2021-2026) Table 120. North America Beauty Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Beauty Peptide Market Share Forecast by Country (2027-2032) Table 122. Europe Beauty Peptide Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 123. Europe Beauty Peptide Sales by Country (2021-2026) & (t) Table 124. Europe Beauty Peptide Sales Market Share by Country (2021-2026) Table 125. Europe Beauty Peptide Sales Forecast by Country (2027-2032) & (t) Table 126. Europe Beauty Peptide Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Beauty Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Beauty Peptide Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Beauty Peptide Market Share by Country (2021-2026) Table 130. Europe Beauty Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Beauty Peptide Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Beauty Peptide Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Beauty Peptide Sales by Country (2021-2026) & (t) Table 134. Asia-Pacific Beauty Peptide Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Beauty Peptide Sales Forecast by Country (2027-2032) & (t) Table 136. Asia-Pacific Beauty Peptide Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Beauty Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Beauty Peptide Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Beauty Peptide Market Share by Country (2021-2026) Table 140. Asia-Pacific Beauty Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Beauty Peptide Market Share Forecast by Country (2027-2032) Table 142. Latin America Beauty Peptide Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 143. Latin America Beauty Peptide Sales by Country (2021-2026) & (t) Table 144. Latin America Beauty Peptide Sales Market Share by Country (2021-2026) Table 145. Latin America Beauty Peptide Sales Forecast by Country (2027-2032) & (t) Table 146. Latin America Beauty Peptide Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Beauty Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Beauty Peptide Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Beauty Peptide Market Share by Country (2021-2026) Table 150. Latin America Beauty Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Beauty Peptide Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Beauty Peptide Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Beauty Peptide Sales by Country (2021-2026) & (t) Table 154. Middle East and Africa Beauty Peptide Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Beauty Peptide Sales Forecast by Country (2027-2032) & (t) Table 156. Middle East and Africa Beauty Peptide Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Beauty Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Beauty Peptide Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Beauty Peptide Market Share by Country (2021-2026) Table 160. Middle East and Africa Beauty Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Beauty Peptide Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Beauty Peptide Distributors List Table 165. Beauty Peptide Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Beauty Peptide Image Figure 2. Global Beauty Peptide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Beauty Peptide Market Size (2021-2032) & (US$ Million) Figure 4. Global Beauty Peptide Sales (2021-2032) & (t) Figure 5. Signal Peptides Image Figure 6. Global Signal Peptides Sales YoY Growth (2021-2032) & (t) Figure 7. Neurotransmitter-Inhibiting Peptides Image Figure 8. Global Neurotransmitter-Inhibiting Peptides Sales YoY Growth (2021-2032) & (t) Figure 9. Carried Peptides Image Figure 10. Global Carried Peptides Sales YoY Growth (2021-2032) & (t) Figure 11. Global Beauty Peptide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Beauty Peptide Market Share by Type 2025 VS 2032 Figure 13. North America Beauty Peptide Sales Market Share in Volume by Type in 2025 Figure 14. North America Beauty Peptide Sales Market Share in Value by Type in 2025 Figure 15. Europe Beauty Peptide Sales Market Share in Volume by Type in 2025 Figure 16. Europe Beauty Peptide Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Beauty Peptide Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Beauty Peptide Sales Market Share in Value by Type in 2025 Figure 19. Latin America Beauty Peptide Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Beauty Peptide Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Beauty Peptide Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Beauty Peptide Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Beauty Peptide Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Anti-ageing Image Figure 26. Global Anti-ageing Sales YoY Growth (2021-2032) & (t) Figure 27. Whitening Image Figure 28. Global Whitening Sales YoY Growth (2021-2032) & (t) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (t) Figure 31. Global Beauty Peptide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Beauty Peptide Market Share by Application 2025 VS 2032 Figure 33. North America Beauty Peptide Sales Market Share in Volume by Application in 2025 Figure 34. North America Beauty Peptide Sales Market Share in Value by Application in 2025 Figure 35. Europe Beauty Peptide Sales Market Share in Volume by Application in 2025 Figure 36. Europe Beauty Peptide Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Beauty Peptide Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Beauty Peptide Sales Market Share in Value by Application in 2025 Figure 39. Latin America Beauty Peptide Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Beauty Peptide Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Beauty Peptide Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Beauty Peptide Sales Market Share in Value by Application in 2025 Figure 43. North America Beauty Peptide Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 44. North America Beauty Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Beauty Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Beauty Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Beauty Peptide Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 48. Europe Beauty Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Beauty Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Beauty Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Beauty Peptide Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 52. Asia-Pacific Beauty Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Beauty Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Beauty Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Beauty Peptide Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 56. Latin America Beauty Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Beauty Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Beauty Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Beauty Peptide Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 60. Middle East and Africa Beauty Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Beauty Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Beauty Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Beauty Peptide Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Beauty Peptide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Signal Peptides
  • Neurotransmitter-Inhibiting Peptides
  • Carried Peptides
Applications
  • Anti-ageing
  • Whitening
  • Others
Companies covered
  • Readline Biotech
  • Pentapharm
  • Pentapharm
  • Lipotec
  • ISP
  • Helix BioMedix
  • Evonil
  • Atrium

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Beauty Peptide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Beauty Peptide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Beauty Peptide Market by Type
  6. 1.3.1 Signal Peptides
  7. 1.3.2 Neurotransmitter-Inhibiting Peptides
  8. 1.3.3 Carried Peptides
  9. 1.4 Global Beauty Peptide Market Size by Type
  10. 1.4.1 Global Beauty Peptide Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Beauty Peptide Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Beauty Peptide Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Beauty Peptide Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Beauty Peptide Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Beauty Peptide Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Beauty Peptide Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Beauty Peptide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Beauty Peptide Industry Trends
  2. 2.2 Beauty Peptide Industry Drivers
  3. 2.3 Beauty Peptide Industry Opportunities and Challenges
  4. 2.4 Beauty Peptide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Beauty Peptide Revenue (2021-2026)
  2. 3.2 Global Top Players by Beauty Peptide Sales (2021-2026)
  3. 3.3 Global Top Players by Beauty Peptide Price (2021-2026)
  4. 3.4 Global Beauty Peptide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Beauty Peptide Major Company Production Sites & Headquarters
  6. 3.6 Global Beauty Peptide Company, Product Type & Application
  7. 3.7 Global Beauty Peptide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Beauty Peptide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Beauty Peptide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Beauty Peptide Tier 1, Tier 2, and Tier 3
4 Beauty Peptide Regional Status and Outlook
  1. 4.1 Global Beauty Peptide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Beauty Peptide Historic Market Size by Region
  3. 4.2.1 Global Beauty Peptide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Beauty Peptide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Beauty Peptide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Beauty Peptide Forecasted Market Size by Region
  7. 4.3.1 Global Beauty Peptide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Beauty Peptide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Beauty Peptide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Beauty Peptide by Application
  1. 5.1 Beauty Peptide Market by Application
  2. 5.1.1 Anti-ageing
  3. 5.1.2 Whitening
  4. 5.1.3 Others
  5. 5.2 Global Beauty Peptide Market Size by Application
  6. 5.2.1 Global Beauty Peptide Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Beauty Peptide Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Beauty Peptide Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Beauty Peptide Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Beauty Peptide Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Beauty Peptide Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Beauty Peptide Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Beauty Peptide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Readline Biotech
  2. 6.1.1 Readline Biotech Company Information
  3. 6.1.2 Readline Biotech Business Overview
  4. 6.1.3 Readline Biotech Beauty Peptide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Readline Biotech Beauty Peptide Product Portfolio
  6. 6.1.5 Readline Biotech Recent Developments
  7. 6.2 Pentapharm
  8. 6.2.1 Pentapharm Company Information
  9. 6.2.2 Pentapharm Business Overview
  10. 6.2.3 Pentapharm Beauty Peptide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pentapharm Beauty Peptide Product Portfolio
  12. 6.2.5 Pentapharm Recent Developments
  13. 6.3 Pentapharm
  14. 6.3.1 Pentapharm Company Information
  15. 6.3.2 Pentapharm Business Overview
  16. 6.3.3 Pentapharm Beauty Peptide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pentapharm Beauty Peptide Product Portfolio
  18. 6.3.5 Pentapharm Recent Developments
  19. 6.4 Lipotec
  20. 6.4.1 Lipotec Company Information
  21. 6.4.2 Lipotec Business Overview
  22. 6.4.3 Lipotec Beauty Peptide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lipotec Beauty Peptide Product Portfolio
  24. 6.4.5 Lipotec Recent Developments
  25. 6.5 ISP
  26. 6.5.1 ISP Company Information
  27. 6.5.2 ISP Business Overview
  28. 6.5.3 ISP Beauty Peptide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 ISP Beauty Peptide Product Portfolio
  30. 6.5.5 ISP Recent Developments
  31. 6.6 Helix BioMedix
  32. 6.6.1 Helix BioMedix Company Information
  33. 6.6.2 Helix BioMedix Business Overview
  34. 6.6.3 Helix BioMedix Beauty Peptide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Helix BioMedix Beauty Peptide Product Portfolio
  36. 6.6.5 Helix BioMedix Recent Developments
  37. 6.7 Evonil
  38. 6.7.1 Evonil Company Information
  39. 6.7.2 Evonil Business Overview
  40. 6.7.3 Evonil Beauty Peptide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Evonil Beauty Peptide Product Portfolio
  42. 6.7.5 Evonil Recent Developments
  43. 6.8 Atrium
  44. 6.8.1 Atrium Company Information
  45. 6.8.2 Atrium Business Overview
  46. 6.8.3 Atrium Beauty Peptide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Atrium Beauty Peptide Product Portfolio
  48. 6.8.5 Atrium Recent Developments
7 North America by Country
  1. 7.1 North America Beauty Peptide Sales by Country
  2. 7.1.1 North America Beauty Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Beauty Peptide Sales by Country (2021-2026)
  4. 7.1.3 North America Beauty Peptide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Beauty Peptide Market Size by Country
  6. 7.2.1 North America Beauty Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Beauty Peptide Market Size by Country (2021-2026)
  8. 7.2.3 North America Beauty Peptide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Beauty Peptide Sales by Country
  2. 8.1.1 Europe Beauty Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Beauty Peptide Sales by Country (2021-2026)
  4. 8.1.3 Europe Beauty Peptide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Beauty Peptide Market Size by Country
  6. 8.2.1 Europe Beauty Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Beauty Peptide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Beauty Peptide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Beauty Peptide Sales by Country
  2. 9.1.1 Asia-Pacific Beauty Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Beauty Peptide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Beauty Peptide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Beauty Peptide Market Size by Country
  6. 9.2.1 Asia-Pacific Beauty Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Beauty Peptide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Beauty Peptide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Beauty Peptide Sales by Country
  2. 10.1.1 South America Beauty Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Beauty Peptide Sales by Country (2021-2026)
  4. 10.1.3 South America Beauty Peptide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Beauty Peptide Market Size by Country
  6. 10.2.1 South America Beauty Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Beauty Peptide Market Size by Country (2021-2026)
  8. 10.2.3 South America Beauty Peptide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Beauty Peptide Sales by Country
  2. 11.1.1 Middle East and Africa Beauty Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Beauty Peptide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Beauty Peptide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Beauty Peptide Market Size by Country
  6. 11.2.1 Middle East and Africa Beauty Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Beauty Peptide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Beauty Peptide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Beauty Peptide Value Chain Analysis
  2. 12.1.1 Beauty Peptide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Beauty Peptide Production Mode & Process
  7. 12.2 Beauty Peptide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Beauty Peptide Distributors
  10. 12.2.3 Beauty Peptide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst